In the case of prostate cancer, exosomal androgen receptor splicing variant 7 (ARv7) and P-glycoprotein (P-gp) encoded by MDR1 gene have been reported to be useful for diagnosis of drug resistance. This evidence concerns the gene ABCB1 and prostate carcinoma.